» Articles » PMID: 29257850

EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS

Abstract

Background: The effects of topical application of sucralfate (SCF) on the tissue content of MUC-2 protein have not yet been evaluated in experimental models of diversion colitis.

Aim: To measure the tissue content of MUC-2 protein in the colonic mucosa diverted from fecal stream submitted to the SCF intervention.

Methods: Thirty-six rats underwent derivation of intestinal transit through proximal colostomy and distal mucous fistula. The animals were divided into three groups which were submitted application of enemas with saline, SCF 1 g/kg/day and SCF 2 g/kg/day. Each group was divided into two subgroups, according to euthanasia was done after two or four weeks. The colitis diagnosis was established by histopathological study and the inflammatory intensity was evaluated by previously validated scale. The MUC-2 protein was identified by immunohistochemistry and the tissue content was measured computerized morphometry).

Results: The application of enemas with SCF in the concentration of 2 g/kg/day reduced inflammatory score of the segments that were diverted from fecal stream. The content of MUC-2 in diverted colon of the animals submitted to the intervention with SCF, independently of intervention period and the used concentration, was significantly greater than animals submitted to the application of enemas containing saline (p< 0.01). The content of MUC-2 after the intervention with SCF in the concentration of 2 g/kg/day was significantly higher when compared to the animals submitted to the application containing SCF at concentration of 1.0 g/kg/day (p<0.01). The tissue content of MUC-2 reached the highest values after intervention with SCF in the concentration of 2 g/kg/day for four weeks (p<0.01). Conclusion: The preventive application of enemas containing SCF reduces the inflammatory score and avoids the reduction of tissue content of MUC-2, suggesting that the substance is a valid therapeutic strategy to preserve the mucus layer that covers the intestinal epithelium.

Citing Articles

Mucin levels in glands of the colonic mucosa of rats with diversion colitis subjected to enemas containing sucralfate and n-acetylcysteine alone or in combination.

Brasil V, Siqueira R, Campos F, Yoshitani M, Pereira G, Mendonca R Acta Cir Bras. 2023; 38:e384023.

PMID: 37851785 PMC: 10578094. DOI: 10.1590/acb384023.


EXPRESSION OF E-CADHERIN AND CLAUDIN-3 IN THE COLONIC EPITHELIUM AFTER THE INFLIXIMAB THERAPY: EXPERIMENTAL MODEL OF DISUSE COLITIS.

Alves Jr A, Goto E, Pereira J, Domingues F, Avila M, Coy C Arq Bras Cir Dig. 2022; 34(4):e1639.

PMID: 35107501 PMC: 8846491. DOI: 10.1590/0102-672020210002e1639.


Sucralfate enemas reduce the oxidative tissue damage and preserves the contents of E-cadherin and ?-catenin in colonic mucosa without fecal stream.

Sato D, Campos F, Kotze P, Mendonca R, Kanno D, Pereira J Acta Cir Bras. 2021; 36(10):e361007.

PMID: 34852133 PMC: 8650803. DOI: 10.1590/ACB361007.


Infliximab Increases the Tissue Contents of Type-I and Type-III Collagen in Colorectal Segments Without Fecal Stream After Hartmann's Procedure.

Freitas B, Campos F, Kanno D, Delben A, Pereira J, Mendonca R J Gastrointest Surg. 2021; 26(3):662-664.

PMID: 34561770 DOI: 10.1007/s11605-021-05138-3.

References
1.
Sauer J, Richter K, Pool-Zobel B . Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J Nutr Biochem. 2007; 18(11):736-45. DOI: 10.1016/j.jnutbio.2006.12.012. View

2.
Laudanno O, Bedini O, Cesolari J, San Miguel P . Evidence of anti-oxidant role of sucralfate in gastric mucosal protection. Ital J Gastroenterol. 1990; 22(1):19-21. View

3.
Willemsen L, Koetsier M, van Deventer S, van Tol E . Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003; 52(10):1442-7. PMC: 1773837. DOI: 10.1136/gut.52.10.1442. View

4.
Gibson G, Roberfroid M . Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995; 125(6):1401-12. DOI: 10.1093/jn/125.6.1401. View

5.
Glotzer D, Glick M, Goldman H . Proctitis and colitis following diversion of the fecal stream. Gastroenterology. 1981; 80(3):438-41. View